Tango Therapeutics TNGX 深 沪
等待开盘 12-19 09:30:00 美东时间
8.46
-0.320
-3.64%
华盛通- 最 高9.00
- 今 开8.87
- 成交量 193.79万股
- 最 低 8.415
- 昨 收 8.78
- 总市值 11.42亿
- 52周最高 11.20
- 市盈率 静 --
- 换手率 1.44%
- 52周最低 1.03
- 委 比 53.53%
- 总股本 1.35亿
- 历史最高 18.84
- 量 比 0.78
- 振 幅 6.66%
- 历史最低 1.03
- 每 手 1
- 风险率 2.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
Tango Therapeutics CEO Barbara Weber will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:45am PST/12:45pm EST. A live webcast and replay will be available on the company's website. Tango Therapeutics is a biotech company focused on precision medicine for cancer treatment using synthetic lethality principles.
12-17 12:00
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immu...
12-12 23:47
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
Stifel Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $15
Stifel analyst Laura Prendergast initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $15.
12-05 00:58
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
<p>Tango Therapeutics announced that Adam Crystal, M.D., Ph.D., its President of Research & Development, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025, at 1:30pm ET. The event will be webcast live on the Company's website under the "Events & Presentations" tab on the Investors page, with a replay available for 90 days post-event. Tango Therapeutics is a clinical-stage biotech compan...
11-26 12:00
Tango Therapeutics launches $100M at-the-market stock offering
Tango Therapeutics (TNGX) entered a sales agreement with Leerink Partners to sell up to $100M of common stock through an at-the-market offering. Leerink Partners will use commercially reasonable effor...
11-21 22:04
Tango Therapeutics Enters New Sales Agreement with Leerink
Tango Therapeutics ( ($TNGX) ) has provided an update. On November 21, 2025, Ta...
11-21 21:58
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
Barbara Weber, President and CEO of Tango Therapeutics, will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference on November 19, 2025, at 4:30-4:55 PM GMT / 11:30-11:55 AM ET. The live webcast will be available on the Company's website under the "Events & Presentations" tab, with a replay archived for 90 days. Tango Therapeutics is a clinical-stage biotechnology company focused on discovering novel drug targets and d...
11-12 12:00
